Nautilus Biotechnology, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Nautilus Biotechnology, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No other changes.
No other changes.
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Largest filed tie
0
filed ties
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
No thesis.
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Same SIC code · 6
Same SEC industry code: Agilent Technologies, Inc., Waters Corp, Mettler Toledo International Inc/ and 3 more; no measured co-movers for Nautilus Biotechnology, Inc..
Same SIC code · 6
Same SEC industry code: Agilent Technologies, Inc., Waters Corp, Mettler Toledo International Inc/ and 3 more; no measured co-movers for Nautilus Biotechnology, Inc..
Nautilus Biotechnology, Inc.
2.25
Tall tick = annual report · Source: EDGAR
Bull2
Bear2
| Manager | Value | % base | |
|---|---|---|---|
| Perceptive | $21.8M | 23.20% | −7.62% |
| AH Capital Management | $16.9M | 18.07% | −48.66% |
| Cercano | $13.4M | 14.30% | 0.00% |
| BlackRockindex-like | $5.0M | 5.36% | +1331.88% |
| Vanguardindex-like | $4.8M | 5.08% | +0.17% |
| Manager | Value | % base | |
|---|---|---|---|
| Perceptive | $21.8M | 23.20% | −7.62% |
| AH Capital Management | $16.9M | 18.07% | −48.66% |
| Cercano | $13.4M | 14.30% | 0.00% |
| BlackRockindex-like | $5.0M | 5.36% | +1331.88% |
| Vanguardindex-like | $4.8M | 5.08% | +0.17% |
Expected move
Inputsspot 2.35exp Mar 19ATM strike 2.5ATM straddle 1.60IV 141%